The story of HUMIRA® started with a fundamental scientific challenge at the LMB. The tool devised to solve this has led to medical applications benefitting ...

5 сент. 2018 г. · Discover the story behind Humira, AbbVie's groundbreaking drug. Explore its development, impact on autoimmune disease treatment, and future ...

17 февр. 2017 г. · Abbott gave the drug the name Humira, an acronym for human monoclonal antibody in rheumatoid arthritis. Humira received FDA approval for the ...

Serious infections have happened in people taking HUMIRA. These serious infections include tuberculosis (TB) and infections caused by viruses, fungi, or ...

28 янв. 2023 г. · Through its savvy but legal exploitation of the U.S. patent system, Humira's manufacturer, AbbVie, blocked competitors from entering the market.

Adalimumab, sold under the brand name Humira and others, is a disease-modifying antirheumatic drug and monoclonal antibody used to treat rheumatoid arthritis.

25 авг. 2022 г. · FDA approval history for Humira (adalimumab) used to treat Rheumatoid Arthritis, Psoriatic Arthritis, Crohn's Disease, Active, ...

24 авг. 2018 г. · Humira, an arthritis medication with indications for colitis and psoriasis, is the world's bestselling drug, but it has not been all plain sailing for AbbVie.

31 янв. 2023 г. · Humira losing its monopoly creates the biggest test the fledgling U.S. biosimilars market has ever faced. It's a market critical to containing ...

4 дек. 2018 г. · “Humira is an anti-TNF monoclonal antibody that currently treats Crohn's disease, rheumatoid arthritis, ulcerative colitis, ...